Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released Nov 8, 2021, after the close
10-Q filed Nov 9, 2021, 40 days after period end · 0001564590-21-055347
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Revenue | $131.61M | $120.58M | $94.59M | $58.31M |
| Net Income | -$14.46M | -$84.66M | -$41.98M | -$62.14M |
| EPS Diluted |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.09 |
| -$0.05 |
| -$0.29 |
| -$0.50 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
